Journal
BIOSENSORS-BASEL
Volume 11, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/bios11100369
Keywords
SARS-CoV-2; COVID-19; point of care testing; rapid diagnostics
Funding
- Australian Research Council [DP170103704, DP180103003]
- National Health and Medical Research Council [APP1143377, IH150100028]
- Australia-China Joint Research Center
Ask authors/readers for more resources
During the COVID-19 pandemic, it is essential to develop an easy-to-use, rapid, and portable system for detecting SARS-CoV-2. Our developed device has a high limit of detection and is suitable for use in crisis centers, mobile laboratories, remote locations, or airports.
The COVID-19 pandemic has changed people's lives and has brought society to a sudden standstill, with lockdowns and social distancing as the preferred preventative measures. To lift these measurements and reduce society's burden, developing an easy-to-use, rapid, and portable system to detect SARS-CoV-2 is mandatory. To this end, we developed a portable and semi-automated device for SARS-CoV-2 detection based on reverse transcription loop-mediated isothermal amplification followed by a CRISPR/Cas12a reaction. The device contains a heater element mounted on a printed circuit board, a cooler fan, a proportional integral derivative controller to control the temperature, and designated areas for 0.2 mL Eppendorf(R) PCR tubes. Our system has a limit of detection of 35 copies of the virus per microliter, which is significant and has the capability of being used in crisis centers, mobile laboratories, remote locations, or airports to diagnose individuals infected with SARS-CoV-2. We believe the current methodology that we have implemented in this article is beneficial for the early screening of infectious diseases, in which fast screening with high accuracy is necessary.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available